SCHOTT Pharma AG & Co. KGaA Market Cap ($2.39 Billion)
Market Cap & Net Worth: SCHOTT Pharma AG & Co. KGaA (1SXP)
SCHOTT Pharma AG & Co. KGaA market cap. SCHOTT Pharma AG & Co. KGaA (XETRA:1SXP) has a market capitalization of $2.39 Billion (€2.05 Billion) as of November 4, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #5395 globally and #871 in its home market, demonstrating a -2.53% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SCHOTT Pharma AG & Co. KGaA's stock price €25.05 by its total outstanding shares 150614616 (150.61 Million). Also see 1SXP cash generation efficiency for how efficiently the company converts equity into cash flow.
SCHOTT Pharma AG & Co. KGaA Market Cap History (2023–2026)
SCHOTT Pharma AG & Co. KGaA market cap history from 2023 to 2026. Data shows change from $5.89 Billion to $4.41 Billion (-6.82% CAGR). Check SCHOTT Pharma AG & Co. KGaA stock price for real-time trading data and today's change.
SCHOTT Pharma AG & Co. KGaA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SCHOTT Pharma AG & Co. KGaA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 1SXP net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
4.63x
SCHOTT Pharma AG & Co. KGaA's market cap is 4.63 times its annual revenue
Latest Price to Earnings (P/E) Ratio
29.60x
SCHOTT Pharma AG & Co. KGaA's market cap is 29.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $5.89 Billion | $898.60 Million | $151.84 Million | 6.56x | 38.82x |
| 2024 | $4.43 Billion | $957.09 Million | $149.69 Million | 4.63x | 29.60x |
Competitor Companies of 1SXP by Market Capitalization
Companies near SCHOTT Pharma AG & Co. KGaA in the global market cap rankings as of November 4, 2026. Also see 1SXP current and non-current assets for a full breakdown of the balance sheet.
Key companies related to SCHOTT Pharma AG & Co. KGaA by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #175 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #249 globally with a market cap of $101.18 Billion USD ( €86.54 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #419 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #537 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #175 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $436.87 |
| #249 | EssilorLuxottica S. A. | PA:EL | $101.18 Billion | €186.90 |
| #419 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €93.00 |
| #537 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of SCHOTT Pharma AG & Co. KGaA (2023–2026)
Market capitalization of SCHOTT Pharma AG & Co. KGaA from 2023 to today. Between 2023 and today, SCHOTT Pharma AG & Co. KGaA's market cap moved from $5.89 Billion to $ 4.41 Billion, with a yearly change of -6.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €4.41 Billion | +65.89% |
| 2025 | €2.66 Billion | -39.98% |
| 2024 | €4.43 Billion | -24.83% |
| 2023 | €5.89 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of SCHOTT Pharma AG & Co. KGaA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.39 Billion USD |
| MoneyControl | $2.39 Billion USD |
| MarketWatch | $2.39 Billion USD |
| marketcap.company | $2.39 Billion USD |
| Reuters | $2.39 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a… Read more